AAAAAA
Results:
1-12
|
Results: 12
Authors:
Hensley, ML
Hoppe, B
Leon, L
Sabbatini, P
Aghajanian, C
Chi, D
Spriggs, DR
Citation: Ml. Hensley et al., The costs and efficacy of liposomal doxorubicin in platinum-refractory ovarian cancer in heavily pretreated patients, GYNECOL ONC, 82(3), 2001, pp. 464-469
Authors:
Maluf, FC
Sabbatini, P
Schwartz, L
Xia, JR
Aghajanian, C
Citation: Fc. Maluf et al., Endometrial stromal sarcoma: Objective response to letrozole, GYNECOL ONC, 82(2), 2001, pp. 384-388
Authors:
Hensley, ML
Lebeau, D
Leon, LF
Venkatraman, E
Waltzman, R
Sabbatini, P
Almadrones, L
Chi, D
Spriggs, D
Citation: Ml. Hensley et al., Identification of risk factors for requiring transfusion during front-linechemotherapy for ovarian cancer, GYNECOL ONC, 81(3), 2001, pp. 485-489
Authors:
Makhija, S
Leitao, M
Sabbatini, P
Bellin, N
Almadrones, L
Leon, L
Spriggs, DR
Barakat, R
Citation: S. Makhija et al., Complications associated with intraperitoneal chemotherapy catheters, GYNECOL ONC, 81(1), 2001, pp. 77-81
Authors:
Sabbatini, P
Citation: P. Sabbatini, Contribution of anemia to fatigue in the cancer patient, ONCOLOGY-NY, 14(11A), 2000, pp. 69-71
Authors:
Mock, V
Atkinson, A
Barsevick, A
Cella, D
Cimprich, B
Cleeland, C
Donnelly, J
Eisenberger, MA
Escalante, C
Hinds, P
Jacobsen, PB
Kaldor, P
Knight, SJ
Peterman, A
Piper, BF
Rugo, H
Sabbatini, P
Stahl, C
Citation: V. Mock et al., NCCN Practice Guidelines for cancer-related fatigue, ONCOLOGY-NY, 14(11A), 2000, pp. 151-161
Authors:
Makhija, S
Sabbatini, P
Aghajanian, C
Venkatraman, E
Spriggs, DR
Barakat, R
Citation: S. Makhija et al., Intraperitoneal cisplatin and intravenous paclitaxel in the treatment of epithelial ovarian cancer patients with a positive second look, GYNECOL ONC, 79(1), 2000, pp. 28-32
Authors:
Makhija, S
Sabbatini, P
Barakat, RR
Citation: S. Makhija et al., Intraperitoneal chemotherapy strategies in the treatment of epithelial ovarian carcinoma, CUR OP OBST, 11(1), 1999, pp. 23-27
Authors:
Sabbatini, P
Larson, SM
Kremer, A
Zhang, ZF
Sun, M
Yeung, H
Imbriaco, M
Horak, I
Conolly, M
Ding, C
Ouyang, P
Kelly, WK
Scher, HI
Citation: P. Sabbatini et al., Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancer, J CL ONCOL, 17(3), 1999, pp. 948-957
Authors:
Hensley, ML
Sabbatini, P
Spriggs, D
Citation: Ml. Hensley et al., Implementation of disease management guidelines in patients with advanced ovarian cancer, SEMIN ONCOL, 26(1), 1999, pp. 46-51
Authors:
Husain, A
Sabbatini, P
Spriggs, D
Fennelly, D
Aghajanian, C
Barakat, R
Curtin, J
Venkatraman, E
Hoskins, W
Markman, M
Citation: A. Husain et al., Phase II trial of intraperitoneal cisplatin and mitoxantrone in patients with persistent ovarian cancer, GYNECOL ONC, 73(1), 1999, pp. 96-101
Authors:
Sabbatini, P
McCormick, F
Citation: P. Sabbatini et F. Mccormick, Phosphoinositide 3-OH kinase (PI3K) and PKB/Akt delay the onset of p53-mediated, transcriptionally dependent apoptosis, J BIOL CHEM, 274(34), 1999, pp. 24263-24269
Risultati:
1-12
|